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Abstract In the paper we review the application of two tech-
niques (molecular mechanics and quantum mechanics) to
study the influence of geometry optimization of the steroid
sulfatase inhibitors on the values of descriptors coded their
chemical structure and their free binding energy with the
STS protein. We selected 22 STS-inhibitors and compared
their structures optimized with MM+, PM7 and DFT
B3LYP/6–31++G* approaches considering separately the
bond lengths, angles, dihedral angles and total energies. We
proved that different minimum energy conformers could be
generated depending on the choice of the optimization meth-
od. However, the results indicated that selection of the geom-
etry optimization method did not affect the optimal STS in-
hibitor coordinates, and hence the values of molecular de-
scriptors which describe the 3D structure of the molecule.
To study the interaction pattern of the STS inhibitors (opti-
mized using different methods) with the target receptor we
applied two strategies: AutoDock and PathDock. The docking
studies point out that selection of software to docking simula-
tion is one of the crucial factors determining the binding mode
of STS inhibitors with their molecular target. Other factor is
related to the ligand orientation in the binding pocket. Finally,
obtained results indicate that MM+ and PM7 methods (faster
and less expensive) could be successfully employed to geom-
etry optimization of the STS inhibitors before their docking
procedure as well as for molecular descriptors calculations.
Keywords Steroid sulfatase inhibitors . Geometry
optimization . Molecular docking . Molecular mechanics .
Quantum mechanics
Introduction
Over the past decades, numerous reports have suggested that
the biologically active hormone precursors may affect on cel-
lular proliferation in various cancers [1]. These compounds
(including androgens and estrogens) play an important role
in the development of many diseases, such as hormone-
dependent breast cancer (HDBC) [1]. One approach for treat-
ment of the HDBC involves inhibitors of enzymes responsible
for the biosynthesis of estrogens in peripheral tissues, e.g.,
steroid sulfatase (STS) [1]. The STS catalyses the hydrolysis
reaction of steroid sulphates to their active forms and therefore
plays a crucial role in the formation of biologically active
hormones. The STS hydrolyses, among other, estrone sulfate
(E1S) and dehydroepiandrosteronesulfate (DHEAS) into es-
trone (E1) and dehydroepiandrosterone (DHEA), respectively.
The detailed studies have shown that E1 and DHEA can act as
precursors for the formation of the estrogenic steroids estradi-
ol (E2) and androstenediol (Adiol) [2]. Furthermore, the wide
distribution of the STS in various tissues indicates that the
STS enzyme is involved in numerous physiological and path-
ological conditions [3].
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Because the activity of the STS may cause estrogenic stim-
ulation of HDBC, research work focused on the design and
synthesis of new and more effective agents that inhibit the
STS enzyme is of particular importance and provides a major
challenge for modern medicinal chemistry. In order to avoid
the adverse estrogenic effects, in the recent years, there has
been intensive research toward finding novel inhibitors based
on non-steroidal cores (including coumarin derivatives). The
first potent inhibitor based on the coumarin scaffold with sig-
nificantly reduced estrogenic properties was 4-methyl-couma-
rin-7-O-sulfamate (1), Fig. 1 (COUMATE), which exhibited
good activity with an IC50 value of 380 nM when evaluated
against placental microsomes [4]. Further modification of its
structure led to a wide range of more potent compounds based
on tricyclic coumarin derivatives containing sulfamate moiety
that mimic the ABC rings of the natural substrate, e.g., 667-
COUMATE (2), Fig. 1 (currently in clinical trials) [5]. One of
the strategies employed for generating a lead STS inhibitor
involved replacement of the sulphate group of the natural
enzyme substrate with surrogates or mimics other than
sulfamate moiety, such as phosphates or thiophosphates [6].
Recently, Demkowicz et al. synthesized new phosphate and
thiophosphate esters of tricyclic coumarin derivatives as po-
tent STS inhibitors [7–9]. The most active compound, bis-(6-
oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)
hydrogenthiophosphate (3) (Fig. 1) demonstrated the greatest
inhibitory effect, with IC50 values of 860 nM in enzymatic
assay. Furthermore, the strategy based on introducing of fluo-
rine atoms into the structure of coumarin sulfamate derivatives
was examined. In 2016, the same research group synthesized a
series of fluorinated 3-phenylcoumarin-7-O-sulfamates [10].
The most active compounds designing so far- 3-(3,4-
difluorophenyl)-coumarin-7-O-sulfamate (4), Fig. 1 and
3-(3,4,5-trifluorophenyl)-coumarin-7-O-sulfamate (5), Fig. 1,
inhibited STS activity both with IC50 values of 270 nM.
The described above process of development of new ste-
roid sulfatase inhibitors is expensive, time consuming, and
requires collaboration of experts from different disciplines,
such as: biology, chemistry, biochemistry, pharmacology,
etc. However, according to recently recommended ideas in
designing new drugs [11], this challenging process could be
supported by a computational chemistry [12, 13]. The
computer-aided drug design (CADD) is a valuable and prom-
ising tool [14], especially in the contexts of the rational drug
discovery. Recently, the world’s major pharmaceutical and
biotechnology companies more frequently follow the effec-
tiveness strategies that allow reducing the costly failure of
pharmaceutical candidates in clinical trials by applying differ-
ent types of the computational techniques [12].
The computational methods employed in drug discovery
can be classified into two main approaches: ligand-based drug
design (LBDD) and structure-based drug design (SBDD)
[15–17]. The first approach is applicable in the absence of
information regarding the 3D structure of target molecules
[16]. In this case, the quantitative-structure activity relation-
ships (QSAR) [18] and pharmacophore modelling [19] could
be applied. The presence of experimentally determined struc-
ture of target molecule would allow following the second type
of methodology. This includes the molecular docking (MD)
[20], QM-Polarized Ligand Dicking (QPLD) [21] or/and the
three-dimensional quantitative-structure activity relationships
(3D QSAR) [22, 23].
In the presented work, the application of the SBDD ap-
proach for the rational designing of new steroid sulfatase in-
hibitors is verifying. Due to the fact that the initial step both in
molecular docking and 3D QSAR modelling involves the ge-
ometry optimization of the STS inhibitors, the main goal of
our study (the first step according to application of SBDD) is
to: (i) compare the geometries of the STS inhibitor structures
after the optimization with methods differ in theory level; (ii)
evaluate the impact of the geometry optimization on the
values of descriptors coded chemical structure of STS inhibi-
tors, and then, (iii) verify if the method applied to optimize the
structures influence their free binding energy with the STS
protein.
Methodology
Comparison of the STS-inhibitors’ geometries obtained
at different theory level
The molecular models of the 22 STS inhibitors presented in
this study were built with the use of Gauss View [23] software.
Chemical structures of the inhibitors were provided in Table 1.
Then, the geometry of the compounds was optimized in the
vacuum by two different methods: (i) the molecular mechan-
ics (MM) using the MM+ force field and the Polak-Ribiere
conjugate gradient algorithm terminating at the gradient of



















R1, R2 = F; R3 = H 4
R1, R2, R3 = F 5
Fig. 1 Chemical structures of the STS inhibitors (1–5)
Struct Chem







































































































































































































































the HyperChem [25] software and quantum mechanics (QM)
using (ii) semi-empirical PM7 level was performed with the
MOPAC 2012 [26] software; and (iii) Density Functional
Theory (DFT) with Becke’s Three Parameter Hybrid
Method with the LYP (Lee-Yang-Parr) correlation functional
(B3LYP) [27, 28] was applied as an ab initio algorithm. The
6–31++G* [29, 30] Pople’s style, one-electron basis set was
utilized. The DFT (B3LYP) calculations were performed with
Gaussian 09 software> [31].
After geometry optimization we performed a Wilcoxon’s
tests for examining if the selected optimization methods influ-
ence the average bond lengths of the studied STS inhibitors.
Subsequently, in order to obtain a deeper insight into the ge-
ometry optimization of selected compounds we compared in-
dividually their bond lengths, angles and dihedral angles at
used data obtained in all calculations’ levels (MM+, PM7,
DFT B3LYP/6–31++G*).
The influence of the geometry optimization on the values
of descriptors coded the chemical structure of the STS
inhibitors
For compounds optimized at different theory level we calcu-
lated the 3D so-called molecular descriptors (840 descriptors),
which describe the three dimensional structure of a particular
compound. The descriptors were calculated with Dragon (ver-
sion 6.0) software [32]. Then, we performed a series of statis-
tical calculation (Wilcoxon’s tests) for examining if the select-
ed optimization methods influence on the descriptors’ values.
In this way, we were able to establish if the differences be-
tween value descriptors were significant.
The influence of the geometry optimization on the free
binding energy of steroid sulfatase inhibitors with STS –
molecular docking
Protein preparation
The X-ray structure of the human steroid sulfatase (STS) was
taken from the Protein Databank (PDB ID: 1P49) and pre-
pared for docking using the following procedure: (i) the cata-
lytic amino acid FGly75 (formylglycine) was converted to the
gem-diol form using the Discovery Studio visualizer
(http://accelrys.com/products/collaborative-science/biovia-
discovery-studio/visualization.html), (ii) the waters of crystal-
lization were removed from the structure, (iii) polar hydrogen
atoms were added to the protein, and (iv) gasteiger charges
were added to each atom and the non-polar hydrogen atoms
were merged to the protein structure employing Autodock
Tools 1.5.6. [33].
The distance between donor and acceptor atoms that form a
hydrogen bond was defined as 1.9 Åwith a tolerance of 0.5 Å,
and the acceptor–hydrogen–donor angle was not less than
120°. The structure was then saved in PDB file format for
PatchDock docking and in PDBQT file format for docking
s tud ies in Autodock Vina 1 .1 .2 sof tware [33] ,
(http://autodock.scripps.edu/resources/references).
Ligand preparation
The STS inhibitors presented in Table 1 (optimized at above
describe three levels of theory: (i) MM+, (ii) PM7 and (iii)
DFT B3LYP 6–31++G*) were analysed in order to select
compounds structurally similar to 667-COUMATE that was
thoroughly studied according to mode of inhibitor binding to
STS [34]. Hierarchical cluster analysis (HCA) with Euclidian
distances and Ward’s method of linkage [34] was applied.
Selected inhibitors were saved as PDB file format for input
to PatchDock software [35]. To carry out docking study in
AutodockVina 1.1.2 software, all the ligand structures were
saved also in PDBQT file format in Autodock Tools 1.5.6.
[33].
Docking studies
AutoDock The docking of the optimized inhibitors into the
prepared rigid structure of the human steroid sulfatase protein
was performed using the Autodock Vina 1.1.2 software [33].
For a l l the docking s tudies , a gr id box size of
30 Å × 30 Å × 30 Å centred on the Cβ atom of the amino
acid FGly75 was used. The centre of the box was set at ligand
centre and grid energy calculations were carried out. For the
AutoDock docking calculation, default parameters were used
and the 20 docked conformations were generated for each
compound. The energy calculations were performed
employing the genetic algorithms (GAs). All dockings were
taken into 2.5 million energy evaluations for each of the test
molecules. In order to verify the reproducibility and validation
of the docking calculations, 667-COUMATE was submitted
as reference molecule for one-ligand run calculation. The ac-
tive pocket consisted of identical amino acid residues for 667-
COUMATE from literature [7] suggesting that this method is
valid enough to be used for docking studies of other test li-
gands. Docking of all ligands to protein was performed using
AutoDock following the same protocol used for reference
compound. Docked ligand conformations were analysed in
terms of energy, hydrogen bonding, and hydrophobic interac-
tion between ligand and receptor protein human STS.
PatchDock The PatchDock [35] is geometry-based molecular
docking open source web software designed to find docking
transformations facilitating excellent molecular shape comple-
mentarity. Such transformations, when applied, induce both
wide interface areas and small amounts of steric clashes which
ensured to include numerous matched local features of the
docked molecules that have complementary characteristics.
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Therefore, we decided to use PatchDock docking to compare
the results of AutoDock and make the study using the ap-
proach proved to be more accurate one.
As it is a web-based software, both the prepared rigid pro-
tein and ligands saved in the PDB format were uploaded.
Followed by root mean square deviation (RMSD) value set
to 1.5 clustering is applied to the candidate solutions to discard
redundant solutions. Each candidate transformation is further
evaluated by a scoring function that considers both geometric
fit and atomic desolvation energy [35]. The geometric score,
the desolvation energy, the interface area size and the actual
rigid transformation of the solution were provided in the out-
put file to judge the best possible docked conformations. The
main reason behind PatchDock’s high efficiency is its fast
transformational search, which is driven by local feature
matching rather than brute force searching of the six-
dimensional transformation space.
Finally, we compared the free binding energy from the
docking calculations with the experimental values. This was
performed in order to investigate the influence of the geometry
optimization method on the free binding energy of the ligand
and the STS active site.
Results and discussion
Comparison of geometries of STS-inhibitors obtained
at different theory level
The geometries of the 22 steroid sulfatase inhibitors (see
Table 1) were optimized with application of two methods
differing in theory level. We have applied: (i) the molecular
mechanics using the MM+ force field and the Polak-Ribiere
conjugate gradient algorithm terminating at the gradient of
0.05 kcal mol−1 Å−1; (ii) the quantum-mechanics using
semi-empirical PM7 level; and DFT B3LYP with the 6–
31++G* basis set. The application of DFT B3LYP 6–31++
G* method for coumarin derivatives was previously verified
[36, 37].
In order to compare the obtained geometries, we have taken
into account three parameters describing geometry: (i) bond
lengths; (ii) angles; and (iii) dihedral angles [36–38]. First, we
have considered bond lengths. Thus, we have calculated av-
erage bond lengths (sum of bond lengths divided by number
of bonds) for each STS-inhibitor. Then, we performed a series
of the statistical Wilcoxon’s tests (at 1% level of confident),
comparing the average bond lengths obtained for the whole
set of structures optimized at different calculation levels.
According to the obtained results, Table 2, it can be noticed
that there are no statistically significant differences related to
average bond lengths computed with applied methods.
In the next step we compared the bond lengths, angles and
dihedral angles individually for each STS-inhibitor. Figure 2
presented the result for one structure (j, Fig. 2A). For the
results related to other selected studied inhibitors please refer
to the Supplementary Info (Table S1). The comparison of
particular bond lengths for geometries computed at different
theory levels (Fig. 2B) allows us to confirm results obtained
using approach with average bond lengths: there are negligi-
ble differences between the bond length; the most significant
are related to structures optimized with the MM+ method in
comparison with the PM7 and DFT B3LYP 6–31++G* ones.
Similar results were noticed comparing angles between par-
ticular atoms in STS-inhibitors’ structures (Fig. 2C).
Simultaneously, the highest impact of geometry optimization
was observed in the case of the dihedral angles measured
between planes containing central atom that can be rotated.
This differences were the most significant for compounds op-
timized with the MM+ method (Fig. 2D), which is reasonable
considering the theory level that this technique is based on.
The region of the systemwhere the optimization process takes
place, for example bond breaking and formation is larger in
MM approach than in QM ones [39]. This means that in case
of the MM method more significant changes in the structures
are possible. Analysis of the change in energy of the com-
pounds as a function of angle of torsion about the O12-P13
bond indicates that in this approach various conformers are
created.
Due to the fact that there are differences in geometries
suggesting that optimization method influences the type of
conformer creation, we decided to evaluate the energies of
structures obtained in each optimization. Therefore, we have
calculated for each structure its total energy.
The total energies (TEs), calculated with the DFT B3LYP/
6–31++G* method for optimized geometries are similar re-
gardless of applied method of optimization, Table 3. This
indicates that all the obtained structures, even though there
are differences in geometries, are on the same energy level.
It confirms that these differences are related to differences in
conformer creation [40]. Additionally, to verify if this energy
is the most favourable one, the application of two approaches
applied so far separately has been used together. Such ap-
proach is recommended in order to gain structure in its global
minimum considering its total energy [41]. Therefore, geom-
etries of the selected STS-inhibitors optimized with the MM+
technique were once more optimized with the DFT B3LYP/6–
31++G* approach. To obtain the representative subset of
Table 2 Results of Wilcoxon test for comparison of average bond
lengths of each STS-inhibitor
Tmin Tα=0,001
MM+ vs. PM7 35 30
MM+ vs. DFT B3LYP 6-31++G* 56
PM7 vs. DFT B3LYP 6-31++G* 32
Struct Chem
inhibitors, we selected compounds differing in their chemical
s t ructures . We obtained the fol lowing energies:
TE(f) = −5.464*106 kJmol−1, TE(j) = −3.403*106 kJmol−1,
TE(m) = −5.466*106 kJmol−1, TE(n) = −4.186*106 kJmol−1,
TE(s) = −3.454*106 kJmol−1. Energies were similar to the
ones computed in previously applied methods. This confirms
that regardless of the applied method structures representing
their most favourable energy are obtained.
Moreover, we have compared also the geometry of com-
pounds optimized with MM+/DFT B3LYP/6–31++G* ap-
proach with the previously applied ones. According to the
obtained results, Figures S1-S3, one can notice that the choice
of the applied method poses the highest impact on the dihedral
angles between planes including the central atom that can be
rotated (e.g. dihedral angle created by atoms of functional
group of compound j). Taking into account that the total en-
ergies computed for STS-inhibitors are similar, as we have
proven above, one can conclude that the method of optimiza-
tion has impact on the type of molecular conformer creation
[36, 42]. The application of the PM7 and the DTF B3LYP/6-
31++G* approach allow obtaning the same conformer.
Application of the method based on molecular mechanics
forces the creation of another type of conformer.
The influence of the geometry optimization on the values
of the descriptor coded chemical structure of the STS
inhibitors
In order to obtain deeper insight into the geometry optimiza-
tion results we have performed further analysis that tested the
influence of the chosen optimization method (MM+, PM7,
DFT B3LYP/6-31++G*) on the molecular descriptor values.
In the comparison study we chose descriptors, which might be
affected by the 3D structure of the molecule. We selected
a b
c d
Fig. 2 a Chemical structure of 6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl dihydrogenphosphate; b its bond lengths, c angles and d dihedral
angles at various calculations’ levels
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groups of 3D descriptors such as: Radial Density Function
descriptors (RDF), 3D-MOlecule Representation of
Structures based on Electron diffraction (3D-MoRSE),
Weighted Holistic Invariant Molecular descriptors (WHIM),
GEometry, Topology and Atom-Weight Assembly descriptors
(GETAWAY), Molecular properties and Drug-like indices.
Then, each group of selected descriptors was divided into
smaller sub-groups connected to their weighting scheme (un-
weighted (u), weighted bymass (m), by van derWaals volume
(v), by Sanderson electronegativity (e), by polarizability (p),
by ionization potential (i), and by I-state (s). Afterwards, we
have compared descriptor values for each STS inhibitor with
its analogue from the sub-group optimized with different op-
timization methods. We have applied a series of statistical
Wilcoxon’s tests (at 1% level of confidence). The number of
performed test was equal to the number of the descriptor’s
sub-group for each STS inhibitor.
According to the results presented in Fig. 3 we have de-
duced, that there are groups of descriptors, which are sensitive
on the geometry optimization method. The RDF descriptors
(which describe the distance distribution in the molecule) ex-
hibited significant different values for several STS inhibitor
descriptors comparing the structure optimized with DFT
B3LYP/6-31++G* and MM+ (panel B, sub-groups 1-7).
This suggest that similar values of the RDF descriptors were
calculated only for the STS inhibitor’s structure optimized
with PM7 and MM+ (panel C, sub-group 1-7), and PM7
and B3LYP/6-31++G* (panel A, sub-group 1-7). In the case
of the 3D-MoRSE descriptors (group which is based on the
electron diffraction, where the weighted scheme could be used
to identify the presence of specific molecular fragments) only
for few compounds the differences in descriptor values (ob-
tained after optimization by all three methods) are significant.
WHIM weighted and unweighted descriptors (which deliver
information about the molecule’s 3D structure, regarding mo-
lecular size, shape, symmetry and atom distribution) constitute
the class where the influence of the different optimization
methods can be negligible (with only few exceptions from this
trend). On the other hand, in the case of WHIM total descrip-
tors one can notice that in all the compared optimization
methods (panels A-C, sub-group 22) the differences in the
descriptor values are significant. This is most noticeable in
comparison of the PM7 and MM+ methods (panel C), where
19 of the 22 compounds have statistically different descriptor
values. Next, the group of GETAWAY descriptors seems to be
the most affected by the geometry optimization methods. The
Table 3 Comparison of total energy calculated with the DFT B3LYP 6–31++ G* method for geometries obtained at different theory levels
Energya
Method of geometry optimization MM+ B3LYP/ 6–31++G* PM7
Total energy ×10−6 [kJ mol−1] a −4.997 −4.997 −4.997
b −4.216 −4.216 −4.216
c −4.476 −4.476 −4.476
d −4.840 −4.840 −4.840
e −4.777 −4.777 −4.777
f −5.464 −5.465 −5.465
g −4.847 −4.848 −4.848
h −6.150 −6.150 −6.150
i −6.047 −6.047 −6.047
j −3.403 −3.403 −3.403
k −3.506 −3.506 −3.506
l −5.363 −5.363 −5.363
m −5.466 −5.466 −5.466
n −4.186 −4.186 −4.186
o −5.910 −5.910 −5.910
p −6.116 −6.117 −6.116
q −5.962 −5.962 −5.962
r −6.169 −6.169 −6.169
s −3.454 −3.454 −3.454
t −5.975 −5.975 −5.975
u −5.069 −5.069 −5.069
v −4.914 −4.914 −4.914
a Energy calculated with DFT B3LYP 6–31++ G* method
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GATEWAYs descriptors deliver on one hand the information
about the particular atoms’ influence on the shape of the whole
molecule and their ability to Binteract^with each other, where-
as on the other hand information about spatial distance be-
tween pairs of atoms. There are significant statistical differ-
ences in descriptor values in every optimization method for
the majority of the studied compounds. Only the sub-classes
of unweighted GATEWAYs and GATEWAYs weighted by
ionization potential descriptors are rather not susceptible to
the kind of optimization methods—with few expectations.
What is more, the group of autocorrelation GATEWAY’s
seems to be more sensitive for the molecule’s optimization
method (panels A-C, sub-groups 23–27) than the weighted
GATEWAYs. Finally, according to the results, the Molecular
properties (set of heterogeneous molecular descriptors de-
scribing physico-chemical and biological properties) and
Drug-like index descriptor values for all STS inhibitors do
not significantly differ after all the applied optimization meth-
od (panels A-C, sub-groups 37–38).
Summarizing, we have proved that the selection of
the geometry optimization method did not affect the
optimal STS inhibitor coordinates, and hence the values
of molecular descriptors which describe the 3D structure
of the molecule. This trend was noticed in most classes
of calculated 3D descriptors. In the next step, in order
to verify, if the optimization methods influence the
binding mode of the STS inhibitor to the active site
we performed further analysis.
The influence of the geometry optimization on the free
binding energy of the steroid sulfatase inhibitors with STS
– molecular docking
To compare the influence of the inhibitors’ geometries on their
free binding energy with the steroid sulfatase we have selected
inhibitors structurally similar to 667-COUMATE that was
proven to bind with the binding pocket of the protein [34].
The selection was performed with the application of HCA
with Euclidian distances and Ward’s method of linkage [43].
The similarities were analysed in space of the topological
descriptors.
According to Fig. 4 we selected five compounds to assess
the influence of the STS-inhibitors’ geometries on their bind-
ing with the protein. Selected compounds are as follows: j, k,
l, m and s (Table 1.). All the selected derivatives and the
reference compound (667-COUMATE) were optimized sepa-
rately with application of the three described in the
Methodology section: (i) MM+; (ii) PM7; and (iii) DFT
B3LYP/6-31++G*. In the case of protein, for all the docking
studies, a grid box size of 30 Å × 30 Å × 30 Å centred on the
Cβ atom of the amino acid FGly75was used. The centre of the
box was set at the ligand centre and grid energy calculations
were carried out. The binding energies were computed by
means of molecular docking with application of two pro-
grams: AutoDock and PatchDock. One has to understand that
though the basic approach of all docking software is the same
the algorithm behind the docking technique varies from
Fig. 3 Results of Wilcoxon’s test for 3D descriptors groups
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software to software. Selection of these two software packages
is reasonable because we intend first, to validate the docking
studies and second, to understand the interaction pattern of the
studied molecules with the target receptor.
Meticulous analyses of the ligand-receptor interactions
were carried out, and final coordinates of the ligand and re-
ceptor were saved. The Discovery Studio visualizer
(http://accelrys.com/products/collaborative-science/biovia-
discovery-studio/visualization.html) was employed for
display of the receptor with the ligand-binding site. The
docking of the inhibitors of the human STS with the receptor
(1P49) exhibited well-established bonds with one or more
amino acids in the receptor active pocket. The active pocket
consisted of amino acid residues as Leu74, Arg98, Gly100,
Val101, Leu167, His290, His346, Lys368, Asn447, Val 486
and Phe488.
AutoDock outcome
Docking results for MM+ optimized geometries Docking
studies revealed that the synthesized molecules optimized
through theMM+method showed diverse free binding energy
toward the target protein, ranging from −3.50 to
2.90 kJ*mol−1. Molecule j is characterized by the least free
binding energy of −3.50 kJ*mol−1 among the experimental
compounds by fitting in the active protein sites making inter-
actions with FGly75, Leu74, Arg98, Gly100, Lys368, Phe488
and Asn447. Figure 5 shows a putative enzyme-ligand com-
plex before the recognized inactivation of the STS and the
overlaid best conformations of the four derivatives (j, k, l
and s). Interestingly, the designed STS inhibitors exhibited
similar docked conformation matched with the reference
sulfamate-based STS inhibitor (667-Coumate). For these
compounds, the core structure of coumarin derivatives were
oriented in the centre of the active site and underwent a non-
polar interaction with the side chains of the hydrophobic pock-
et formed by the Leu74, Arg98, Gly100, Val101, Leu167,
His290, Lys368, and Phe488 residues. On the contrary,
though compoundm is surrounded with the same amino acid
residues their orientation was completely opposite of the other
experimental compounds along with COUMATE.
Considering docked conformation, flexible side chain i.e.
thiophosphate derivative of compound m is not able to pro-
vide any form of interactions with Leu74, Arg98, Gly100,
Lys368 and Phe488 due to the alternate orientation which
support higher binding energies comparing to compound j
and the reference compound (Fig. 5).
Docking results for PM7 optimized geometries In silico
studies revealed all the synthesized molecules showed moder-
ate free toward the target receptor, ranging from −4.56 to
−1.03 kJ mol−1. The predicted free binding energy was more
favourable in the case of molecule (j), which led to the lowest
free binding energy of −4.56 kJ mol−1 among the experimen-
tal compounds by fitting exactly in the active sites making
interactions with Arg98, Phe488, Asn447 and Val486.
Figure 6 displays a putative enzyme-ligand complex before
the presumed inactivation of the STS and the superimposed
best conformations of the three derivatives (j, k and s). As
shown in Fig. 6, the designed STS inhibitors exhibited the
same docked conformation compared with the reference
sulfamate-based STS inhibitor (667-Coumate). In this case,
the skeleton of coumarin derivatives were oriented in the cen-
tre of the active site and underwent a non-polar interaction
Fig. 4 Hierarchical Cluster
Analysis of STS-inhibitors in the
space of topological descriptors
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with the side chains of the hydrophobic pocket formed by the
Leu74, Arg98, Gly100, Val101, Leu167, Val486, and Phe488
residues. On the contrary, though compounds like l and m
surrounded with the same amino acid residues their orienta-
tion was completely opposite of the other experimental com-
pounds as well as with the reference compound COUMATE.
In this case, flexible side chain i.e. phosphate derivative can-
not make any form of interactions with Arg98, Phe488,
Asn447 and Val486 due to opposite orientation which support
higher binding energies of compounds l and m comparing to
compound j and the reference compound (Fig. 6). It is inter-
esting to point out that the orientation of compound l for the
other two optimization methods (MM+ and DFT approach)
were completely opposite than the orientation but the orienta-
tion of compound m for all the three methods was the same.
Docking results for DFT B3LYP/6-31++G* optimized ge-
ometriesComparing the free binding energy of the docked
conformation of the studied molecules, compound j is
observed to have the least free binding energy of
−3.96 kJ*mol−1 making interactions with Leu74, Arg98,
Gly100, Lys368, Phe488 and Asn447. Figure 7 shows the
best conformations of the four derivatives j, k, l and s
exhibited comparable docked conformation with the ref-
erence sulfamate-based STS inhibitor 667-Coumate. Like
the MM+ method, the scaffold of the coumarin deriva-
tives was encircled with the side chains of the hydropho-
bic pocket formed by the Leu74, Arg98, Gly100, Val101,
Leu167, Lys368, and Phe488 residues as well as by the
polar amino acids like His290 and Asn447. In this case
also, although the same amino acid residues were making
the cavity for compound m its orientation was completely
reversed than the other experimental compounds along
with COUMATE. Analysing docked conformation, flexi-
ble side chain i.e. the thiophosphate derivative of com-
pound m is not able to make any form of interactions with
Leu74, Arg98, Gly100, Lys368 and Phe488 due to its
opposite orientation which supports its bad binding ener-
gies comparing to the other compounds and the reference
compound (Fig. 7).
Fig. 5 Docked binding modes for the compounds j (Yellow), k (Purple), l (Red), s (Cyan) and COUMATE (black) in left and for the compound m
(Green) in right for MM + method in AutoDock software
Fig. 6 Docked binding modes for the compounds j (Yellow), k (Purple), s (Cyan) andCOUMATE (Black) in left and for the compounds l (Red) andm
(Green) in right for PM7 method in AutoDock software
Struct Chem
PathDock outcome
Docking results for MM+ optimized geometriesMolecules
optimized with the MM+ method led to values within
the atomic contact energy range between −8.7 to
−6 kcal mol−1. The most potent compound m according
to the biological assay showed the best atomic contact
energy of −8.7 kcal*mol−1. The active pocket for the
docked conformation of the synthesized coumarin deriv-
atives along with COUMATE were comprised of amino
acid residues like Arg98, Val 101, Val177, Phe178,
Thr180, Val486 and Phe488. Analysing the inhibitor
enzyme interactions at the atomic level, it can be iden-
tified that the phosphate or phiophosphate moieties of
the j and l compounds were directed toward the Arg98
residue and that their amine groups were able to estab-
lish hydrogen bonds (Fig. 8). This could favour the
binding and may have a significant impact on the
enzyme-ligand complex stability [7]. Interestingly, the
reference compound had shown similar orientation in
the active site pocket like compounds j and l. On the
contrary, in the case of compounds like k, m and s
(Fig. 8), the opposite arrangement of the phosphate or
thiophosphate moieties was noticed. Interestingly, the
reason behind the best free binding energy of compound
m was the chance of making hydrogen bond more
prominently with Thr484 than with the other two com-
pounds k and s due to their slightly shifted orientations
from Thr484.
Docking results for PM7 optimized geometries
Synthesized derivatives optimized with PM7 method
led to values within the atomic contact energy range
between −9.6 to −5.6 kcal mol−1. The most potent com-
pound m according to the biological assay showed the
best atomic contact energy of −9.6 kcal mol−1. The
active pocket for the docked conformation of the syn-
thesized coumarin derivatives consisted of amino acid
residues as Arg98, Val101, Val177, Thr180, Gly181,
His290, Lys368, Thr484, His485, and Phe488.
Analysing the inhibitor enzyme interactions at the atom-
ic level, it can be identified that the phosphate or
thiophosphate moieties of the j, k, m and s compounds
were directed toward the Thr484 residue and that their
OH groups are able to establish hydrogen bonds
(Fig. 9). It is already proven that the identified hydro-
gen bond between the phosphate moieties and the
Thr484 residue could favour the binding and may have
a significant impact on the enzyme-ligand complex sta-
bility [7]. On the contrary, in the case of the compound
l (Fig. 9), the opposite arrangement of the thiophosphate
moiety to the hydroxyl group of Thr484 suggests that a
thiophosphate group transfer may be crucial during the
inactivation process.
Docking results for DFT B3LYP/6-31++G* optimized ge-
ometries Like in all other methods, compoundm showed the
best atomic contact energy of −9.3 kcal mol−1 justifying its
experimental assay result. Docked conformation of all the
synthesized compounds for the DFT method placed among
the following amino acid residues: Arg98, Val101, Val177,
Thr180, His290, Lys368, Thr484, His485, and Phe488.
Docking results revealed that the phosphate or thiophosphate
moieties of compounds k, m and s were directed toward the
Thr484 residue and that their OH groups are able to establish
hydrogen bonds (Fig. 10). Again, for compounds j and l
(Fig. 10), complete opposite arrangement of the phosphate
or thiophosphate moieties to the hydroxyl group of Thr484
suggests that a phosphate or thiophosphate group transfer may
be crucial during the inactivation process.
Fig. 7 Docked binding modes for the compounds j (Yellow), k (Purple), l (Red), s (Cyan) and COUMATE (black) in left and for the compound m
(Green) in right for DFT B3LYP/6-31++G* method in AutoDock software
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The free energy of binding of selected derivatives with STS
was calculated by means of AutoDock and PatchDock and the
results are presented in Table 4.
After obtaining the free binding energy for the STS
inhibitors we compared these values with the experi-
mental ones. In this case, we calculated the binding
affinities according to the formula ΔG = −RTlnKi,
[44]. We adapted the working hypothesis introduced
by Durdagi et al., Naik et al. and Conn et al. that
assume that Ki is equal to the IC50 [μM] [45–47]. The
residual values correspond to the binding energies ob-
tained due to docking procedure (with different theory
level of optimization process) and the experimental
binding affinities calculated for each compound are pre-
sented on the Fig. 11.
Analyses of Table 4 and Fig. 11 suggest that the
PathDock approach is a more adequate method to study
the free binding energy of STS-inhibitors with their
Fig. 8 Docked binding modes for the compounds j (Yellow), l (Red), and COUMATE (Black) in left and for the compound k (Purple), m (Green) s
(Cyan) in right for MM+ method in PatchDock software
Fig. 9 Docked binding modes for the compounds j (Yellow), k (Purple),m (Green) and s (Cyan) in left and for the compounds l (Red) andCOUMATE
(Black) in right for PM7 method in PatchDock software
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molecular target. In the case of AutoDock the residuals
between binding energies calculated by means of experi-
mentally measuring the IC50 value and the ones computed
in docking procedure are much more significant (e.g. re-
sidual for m compound optimized with MM+ method
docked by means of AutoDock is equal to almost
10 kcal mol−1, while in the case of PathDock it is only
2,67 kcal*mol−1). Thus, based on our results the
PathDock docking software is more recommended to
study binding of STS-inhibitors with the STS protein.
According to the PathDock results, it was interesting to
point out that the best agreement between the computed
free binding energy and the experimentally measured ones
(the lowest residuals observed in Fig. 11) is in the case of
derivatives optimized with the MM+ method. However,
differences in residuals obtained for compounds
Table 4 Molecular docking results
ID Optimization Method ΔG (AuthoDock) (kcal mol−1) ΔG (PathDock) (kcal mol−1) IC50 (μM) ΔGa (kcal mol−1)
j MM+ −3.50 −6.0 37.8 −6.03
PM7 −4.56 −5.6
B3LYP/631++G* −3.96 −7.0
k MM+ −1.24 −6.4 21.5 −6.36
PM7 −2.69 −6.6
B3LYP/631++G* −1.74 −6.7
l MM+ −0.03 −7.7 34.9 −6.07
PM7 −2.98 −8.7
B3LYP/631++G* −1.48 −8.5
m MM+ 2.90 −8.7 13.3 −6.64
PM7 −1.03 −9.6
B3LYP/631++G* 0.91 −9.3
s MM+ −0.91 −6.0 79.2 −5.59
PM7 −3.55 −6.1
B3LYP/631++G* −2.43 −6.3
667-coumate MM+ −5.54 −9.3 −
PM7 −5.51 −9.5
B3LYP/631++G* −5.56 −8.6
aΔG - Free binding energy calculated according to the formula ΔG = -RTlnKi [44]
Fig. 10 Docked binding modes for the compounds k (Purple),m (Green), s (Cyan) and COUMATE (Black) in left and for the compounds j (Yellow)
and l (Red) in right for DFT B3LYP/6–31++G* method in PatchDock software
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optimized with different approaches (MM+, PM7 and
DFT B3LYP/6-31++G*) are, in the case of compounds
j, k, and s, negligible, which indicate that the method of
geometry optimization is not the crucial factor in free
binding energy computation by means of docking proce-
dure. This is reasonable taking into account that docking
simulation includes exploration of the best conformation
of the flexible ligand (the energetically most favourable)
to increase the energy of the ligand-receptor interaction
[33, 48]. Therefore, changes in ligand structure during
docking simulation are possible.
The more important factor determining the free bind-
ing energy of STS-inhibitors with the STS protein is
ligand orientation that influences their free binding en-
ergy. In almost all performed docking simulations, com-
pounds l and m bind with the STS protein in different
ways, having opposite orientation in comparison to oth-
er derivatives, regardless of the applied method of ge-
ometry optimization. Moreover, the residuals between
the experimentally measured and the computed free for
these two derivatives (l and m), regardless of the ap-
plied method of geometry optimization and docking
procedure are the highest, which in fact confirms that
the orientation opposite to the reference compounds is
not adequate.
Conclusions
In the presented work, we have evaluated the influence of the
method of geometry optimization on the geometry expression
in bond lengths, angles and dihedral angles of steroid sulfatase
inhibitors. We have employed two methods that differ in the-
ory levels, such as: molecular mechanics (MM+) and quantum
mechanics (DFT B3LYP/6-31++G* and PM7). The obtained
results indicate that application of these techniques allows
obtaining different conformers. Surprisingly, we have re-
vealed that the selection of the geometry optimization method
did not affect the optimal STS inhibitor coordinates, as well as
the values of the molecular descriptors that describe the 3D
structure of the obtained conformers.
Additionally, we have verified the impact of the geometry
optimization method on the free binding energy of steroid
sulfatase inhibitors with the STS protein. The results indicate
that the geometry optimization did not influence significantly
the binding of these compounds with their molecular target.
More crucial factors include: (i) selection of the software to
molecular docking; and (ii) proper orientation of ligand into its
binding pocket.
Thus, taking into account that the time and computational
cost required to perform calculation with MM+ or PM7 meth-
od are much less demanding than for the DFT one, these
Fig. 11 Residuals between free binding energy calculated by means of experimentally measured IC50 and obtained in molecular docking
Struct Chem
methods would be recommended to optimize geometries of
STS inhibitors before their docking procedure, as well as for
molecular descriptor calculations.
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